Navigation Links
Studies show novel device may enhance chemotherapy treatment in brain tumors
Date:11/24/2008

tric fields have shown no effect on non-dividing, healthy cells in the same region, suggesting that the device can treat cancer without harming surrounding tissue, unlike chemotherapies that are typically associated with high toxicity resulting in serious side effects. The Novo-TTF is currently an investigational medical device and is not yet FDA approved.

NovoCure recently published data from its human pilot study for patients with later stage GBM tumors that recurred after surgery and radiation. The results of this study preliminarily indicate that the Novo-TTF more than doubled the median overall survival rates for recurrent GBM patients relative to historical data.

NovoCure is currently conducting a Phase III clinical trial at more than 20 centers in the US and Europe for patients with recurrent GBM and is planning to launch a Phase III clinical trial to evaluate Novo-TTF treatment in combination with standard chemotherapy in patients with newly diagnosed GBM in 2009. Please refer to www.novocuretrial.com or call 1 (800) 978-0265 for more information on the ongoing trial.

SNO STUDY DETAILS

The in vitro study looked at the effects of TTFields alone and in combination with DTIC, a precursor of MTIC (the active metabolite of Temozolomide) in human GBM cells. The results demonstrated that, when applied together with DTIC, TTFields drastically increased the sensitivity of GBM cells in culture to DTIC.

The open-label, single-arm prospective pilot clinical trial evaluated the efficacy and safety of the Novo-TTF device in combination with standard chemotherapy (temozolomide) in 10 patients with newly diagnosed GBM. The results of the study were compared to concurrent and historical control outcomes of standard chemotherapy when given alone. All patients were followed on a monthly basis and received treatment with the device for up to 18 months. The primary endpoints were feasibility, toxicity, time to disease progression
'/>"/>

Contact: Marissa Green
marissa.green@edelman.com
323-202-1463
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting
2. Studies examine treatment for gout and the conditions protective effects
3. Center for Health Enhancement Systems Studies awarded $8.6 million NIH grant
4. Studies Reveal Every Homeowners Dream: You Can Dust Less and Have a Healthier, Cleaner Home
5. Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies
6. Battelle to Perform Verification Studies of IntelligentMDxs Proprietary Molecular Diagnostic Assay Process
7. American Council on Exercise (ACE) Studies Impact of Boot Camp-Style Workouts
8. Studies Ignite Hope for Long-Acting Allergy Vaccines
9. Groundbreaking cancer studies to be unveiled at ASTRO annual meeting
10. Post-marketing studies finding adverse events in drugs used in children
11. Studies refute common stereotypes about obese workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 Current Back2Basics long-term drug rehab ... post foot surgery during his first six months of sobriety. ... – twice on one foot, once on the other– which ... my foot a year ago and was prescribed drugs that ... by a friend from home who’d recently completed the program. ...
(Date:7/29/2014)... 29, 2014 Couples rule at Maui's only ... Wailea. This September through November, the focus is on ... to couples of all ages and interests. Best of ... advantage of the Resort's popular Experience More package , ... yearly sale" is in full swing in the award-winning restaurants, ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Multiple ... organization has announced the appointment of five new members ... the Coalition announced the election of its executive directors. ... 6 Board members and 2 Physician Advisors. These ... MSA Coalition mission of education, support, advocacy and research ...
(Date:7/29/2014)... 2014 Septic tanks have ... This score reflects a buyer's moderate ability to negotiate ... of suppliers, the product's widespread availability and the price-competitive ... Jordan Weinstein. IBISWorld estimates that there are more than ... of supplier options. However, recent demand growth and rising ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Ticketability.com has reduced ... have already been selling at lower prices on the secure ... receive a further discount on tickets that are priced lower ... selection of tickets available at Ticketability.com. , Theatergoers know that ... eager to find Phantom of the Opera tickets for sale ...
Breaking Medicine News(10 mins):Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2
... mouse genetic system co-developed by researchers at the University of ... biologist Hui Zong has isolated the cellular origin for malignant ... oligodendrocyte precursor cells (OPCs) are the point of origin is ... the July 22 issue of the journal Cell . ...
... , THURSDAY, July 7 (HealthDay News) -- The female ancestor ... lived in the vicinity of present-day Britain and Ireland 20,000 ... scientists. It,s likely that climate changes that affected the ... habitats and interbreeding between brown bears and polar bears. This ...
... Identifying a suitable donor for leukemia and lymphoma patients ... now that results of two clinical trials show transplant ... are comparable to fully matched tissue, thanks in large ... special post-transplant chemotherapy. The finding means that nearly ...
... Family doctors are reluctant to disclose identifiable patient ... mostly in an effort to protect patient privacy. A ... Canada Research Chair in Electronic Health Information at the ... Ontario Research Institute recently found that during the peak ...
... Gender may be associated with an increased risk ... knees, according to research being presented at the American ... Diego. "Having articular cartilage lesions ... the knee) is considered a predictor of future osteoarthritis-a ...
... In the largest reported series yet to compare transcervical ... staging and restaging of non-small cell lung cancer (NSCLC), ... research presented at the 14th World Conference on Lung ... the Study of Lung Cancer (IASLC). Diagnostic yield ...
Cached Medicine News:Health News:Cellular origin of deadly brain cancer is identified 2Health News:Cellular origin of deadly brain cancer is identified 3Health News:Female Ancestor of All Living Polar Bears Was Brown 2Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 2Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 3Health News:New report explains why physicians are reluctant to share patient data 2
(Date:7/28/2014)... , July 28, 2014  ALPHAEON ... lifestyle healthcare and subsidiary of Strathspey ... acquired Physician Recommended Nutriceuticals (PRN) ® , a ... related products for dry eye and ... a transaction worth up to $55M. ...
(Date:7/28/2014)... 28, 2014 Concord Medical Services Holdings Limited ... ), a leading specialty hospital management solution provider and ... imaging centers in China , today ... Directors declared a special cash dividend of US$0.30 per ... on the Company,s outstanding ordinary shares. The total expense ...
(Date:7/28/2014)... TOKYO , July 28, 2014 /PRNewswire/ ... appointed Roger Crystal , MD as Vice President ... the Global Business Development Product Acquisition & Licensing team ... in developing business strategy and partnerships in the precision ... to partner with biotechnology and pharmaceutical companies across the ...
Breaking Medicine Technology:ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3Concord Medical Declares Special Dividend 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
... 14, 2011 Life Technologies Corporation ... delivery technology specially designed for therapeutic applications that is ... available for licensing as part of a new out-licensing ... the novel proprietary siRNA delivery reagents by using new ...
... Imaging has achieved proof-of-concept with the first fully automated ... CT angiography (cCTA) study. This technology, the first to ... the potential to eliminate the need for a separate ... decrease patient radiation exposure. This work in progress is ...
Cached Medicine Technology:Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market 2Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market 3Rcadia's Fully Automatic Calcium Score Assessment from Coronary CTA Shows Potential to Eliminate Need for Separate Scan 2
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Central platform with integrated neck. Piston ... utilizing an internal spring to recoil ... Cutting Block fits into precision milled ... blades sized 6.25 - 9.0mm. Designed ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: